L Harborne

780 total citations
9 papers, 581 citations indexed

About

L Harborne is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L Harborne has authored 9 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L Harborne's work include Ovarian function and disorders (8 papers), Reproductive Biology and Fertility (4 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). L Harborne is often cited by papers focused on Ovarian function and disorders (8 papers), Reproductive Biology and Fertility (4 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). L Harborne collaborates with scholars based in United Kingdom and United States. L Harborne's co-authors include Naveed Sattar, Jane E. Norman, Richard Fleming, Helen Lyall, David B. Seifer, Daniel Ling, David T. MacLaughlin, David Preiss, R. Fleming and Ian A. Greer and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Fertility and Sterility.

In The Last Decade

L Harborne

9 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L Harborne United Kingdom	6	477	305	181	93	59	9	581
Yılmaz Şahin Türkiye	14	415 0.9×	246 0.8×	176 1.0×	75 0.8×	59 1.0×	21	551
Ingvar Ek Sweden	9	387 0.8×	253 0.8×	114 0.6×	112 1.2×	28 0.5×	11	513
Virginia Pavone Italy	10	490 1.0×	301 1.0×	176 1.0×	86 0.9×	65 1.1×	13	540
Yaqin Mo China	11	548 1.1×	372 1.2×	82 0.5×	61 0.7×	40 0.7×	20	631
Piotr Skałba Poland	11	299 0.6×	155 0.5×	102 0.6×	92 1.0×	26 0.4×	34	471
Gipsie B. Ranney United States	4	401 0.8×	188 0.6×	184 1.0×	130 1.4×	34 0.6×	7	489
D. Antenucci Italy	4	371 0.8×	238 0.8×	143 0.8×	41 0.4×	39 0.7×	6	440
Vimla Laumas India	7	471 1.0×	335 1.1×	223 1.2×	111 1.2×	56 0.9×	16	651
Pernille Fog Svendsen Denmark	12	270 0.6×	159 0.5×	108 0.6×	81 0.9×	38 0.6×	23	476
Tiina Dietz Germany	6	343 0.7×	176 0.6×	86 0.5×	63 0.7×	18 0.3×	8	465

Countries citing papers authored by L Harborne

Since Specialization

Citations

This map shows the geographic impact of L Harborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Harborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Harborne more than expected).

Fields of papers citing papers by L Harborne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Harborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Harborne. The network helps show where L Harborne may publish in the future.

Co-authorship network of co-authors of L Harborne

This figure shows the co-authorship network connecting the top 25 collaborators of L Harborne. A scholar is included among the top collaborators of L Harborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Harborne. L Harborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Preiss, David, Naveed Sattar, L Harborne, Jane E. Norman, & R. Fleming. (2008). The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice. 62(9). 1337–1343. 35 indexed citations

Harborne, L, Claire Alexander, Andrew J. Thomson, D S O’Reilly, & Ian A. Greer. (2005). Outcomes of pregnancy complicated by thyroid disease. Australian and New Zealand Journal of Obstetrics and Gynaecology. 45(3). 239–242. 8 indexed citations

Fleming, Richard, L Harborne, David T. MacLaughlin, et al.. (2005). Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertility and Sterility. 83(1). 130–136. 75 indexed citations

Harborne, L, Naveed Sattar, Jane E. Norman, & Richard Fleming. (2005). Metformin and Weight Loss in Obese Women with Polycystic Ovary Syndrome: Comparison of Doses. The Journal of Clinical Endocrinology & Metabolism. 90(8). 4593–4598. 125 indexed citations

Sattar, N, et al.. (2003). Evidence for the use of metformin in women with polycystic ovary syndrome. 1 indexed citations

Harborne, L, Richard Fleming, Helen Lyall, Naveed Sattar, & Jane E. Norman. (2003). Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4116–4123. 154 indexed citations

Harborne, L, Richard Fleming, Helen Lyall, Jane E. Norman, & Naveed Sattar. (2003). Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. The Lancet. 361(9372). 1894–1901. 181 indexed citations

Harborne, L, et al.. (2002). Metformin and weight loss in women with polycystic ovary syndrome (PCOS). 4. 1 indexed citations

Harborne, L & Richard Fleming. (2002). A randomized study comparing doses of metformin in obese women with polycystic ovary syndrome (PCOS). Fertility and Sterility. 78. S34–S34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact